Audiologists in Carlisle, PA Accepting Medicare
4 Audiologists found. Showing 1 - 4
 Dr. Thomas J Hladnik Jr., AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 450 Gibner Rd, Carlisle, PA 17013 Phone: 717-961-2478 |
 Lisa B Brown, M.A., CCC-A Audiologist Medicare: Medicare Enrolled Practice Location: 2 Jennifer Ct, Suite B, Carlisle, PA 17015 Phone: 717-243-0616 |
Jill Hoffman, AUD. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1533 Commerce Ave 2, Carlisle, PA 17015 Phone: 717-960-0227 |
Lynn E Fickes, MS, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1533 Commerce Ave, Carlisle, PA 17015 Phone: 717-960-0227 |
News Archive
Timing of meals predicts weight-loss effectiveness
Most weight-loss plans center around a balance between caloric intake and energy expenditure. However, new research has shed light on a new factor that is necessary to shed pounds: timing. Researchers from Brigham and Women's Hospital (BWH), in collaboration with the University of Murcia and Tufts University, have found that it's not simply what you eat, but also when you eat, that may help with weight-loss regulation.
Prosocial norms in open science movement encourage greater diversity and inclusion
The culture of science is changing. Researchers are examining the methods and practices that have long been the basis for scientific research and publication with the goal of improving it.
New life-saving, man overboard boating device wins award
Massey University design graduate Leon Oliver's ‘Sentinel' is designed to protect a crew member who has fallen overboard at sea. The user can climb into a raft, which has been remotely deployed from the vessel by the victim using an electronic watch. The watch is also designed to activate an onboard alarm to alert the crew to the accident.
Phase 3 clinical trial of macimorelin (AEZS-130) to be completed by AEterna Zentaris
AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that it has initiated activities intended to complete the clinical development of the growth hormone secretagogue (GHS) / ghrelin agonist compound macimorelin (AEZS-130) which could be the first oral diagnostic test approved for growth hormone deficiency (GHD). Macimorelin is the International Non-proprietary Name (INN) designated for the compound by the World Health Organization (WHO).
› Verified 5 days ago
Physical Therapists
Speech-Language Pathologists
Occupational Therapists
Optometrists
Chiropractors
Podiatrists
Audiologists